GlaxoSmithKline Shares News & Articles

Why Biogen’s decision to ditch global clinical trials in Alzheimer’s has spooked investors

US biotechnology giant Biogen’s shock decision to discontinue two Phase III clinical trials in Alzheimer’s disease has spooked investors, prompting declines in UK-listed pharmaceutical stocks. Shares in AstraZeneca (AZN) have fallen 2.1% to £63.88 while GlaxoSmithKline (GSK) was broadly unmoved at £15.62 after an initial dip of 0.7%. Over $18bn was wiped off Biogen’s market value on ...

UK dividend yields hit highest level since the global financial crisis – what can investors expect?

Dividend yields on UK shares are at their highest level, 4.8%, since 2009. Dividends continue to grow while concerns over the trade war, Brexit and interest rates drag on sentiment. High yields are typically seen as a warning sign that dividends are unsustainable and are also a sign that stocks are out of favour. In 2018, rising profitability, more special dividends and a weaker pound helped ...
Showing 1 to 20 of 292